ConductScience.org, home

Paper10069780

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.

Miyazaki H and 6 others. Circulation, 1999. Cited by 625 papers, by iCite.

Cite this record

ConductScience Library. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Papers, record 10069780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10069780

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
PubMed
Journal
Circulation
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
625
iCite
Relative citation ratio, by iCite
17.1
iCite
Revised in PubMed
2023-05-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miyazaki HH
2Matsuoka HH
3Cooke JPJ P
4Usui MM
5Ueda SS
6Okuda SS
7Imaizumi TT

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArginineMajor topic
ArteriosclerosisMajor topic
Enzyme InhibitorsMajor topic
Nitric Oxide SynthaseMajor topic
Adult
Aged
Biomarkers
Carotid Artery, Common
Female
Humans
Male
Middle Aged
Risk Factors
Tunica Intima

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02975258Adiposity and Airway Inflammation in HIV-Associated Airway DiseaseBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in10758065Is asymmetric dimethylarginine a novel marker of atherosclerosis?https://conductscience.org/library/papers/10758065

Source PubMed

Download CSV of comments and corrections

Cited by126

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 625 citations.

PMIDTitleJournalYearIn PapersSource
41454082Roles of different methylation modifications in cardiovascular disease.Front Med2025https://conductscience.org/library/papers/41454082PubMed
41264118Asymmetric dimethylarginine as a predictive marker for resistance to high-dose intravenous immunoglobulin in Kawasaki disease.Eur J Pediatr2025https://conductscience.org/library/papers/41264118PubMed
40975125Vascular mechanical forces and vascular diseases.J Adv Res2026https://conductscience.org/library/papers/40975125PubMed
40887468Arterial stiffness and vascular aging: mechanisms, prevention, and therapy.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40887468PubMed
40656163Plasma levels of NO-related pathway molecules to predict post-transcatheter aortic valve implantation major adverse cardiovascular events: a prospective, multicenter study.Postepy Kardiol Interwencyjnej2025https://conductscience.org/library/papers/40656163PubMed
38841406The human intestinal bacterium Eggerthella lenta influences gut metabolomes in gnotobiotic mice.Microbiome Res Rep2024https://conductscience.org/library/papers/38841406PubMed
37623831Decreased 25-Hydroxy Vitamin D Level Is Associated with All-Cause Mortality in Patients with Type 2 Diabetes at High Cardiovascular Risk.Metabolites2023https://conductscience.org/library/papers/37623831PubMed
36789028Cystatin C-based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia.Obes Sci Pract2023https://conductscience.org/library/papers/36789028PubMed
36438601Influence of cardiac function on intermittent hypoxia in rats fed with high-fat diet.Biochem Biophys Rep2022https://conductscience.org/library/papers/36438601PubMed
35177746An early prediction model for chronic kidney disease.Sci Rep2022https://conductscience.org/library/papers/35177746PubMed
35163055An Optimized MRM-Based Workflow of the l-Arginine/Nitric Oxide Pathway Metabolites Revealed Disease- and Sex-Related Differences in the Cardiovascular Field.Int J Mol Sci2022https://conductscience.org/library/papers/35163055PubMed
34901269Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study.Biomed Res Int2021https://conductscience.org/library/papers/34901269PubMed
34604419Association of Serum Asymmetric Dimethylarginine with the Severity of Coronary Artery Disease: A Pilot Study.Rep Biochem Mol Biol2021https://conductscience.org/library/papers/34604419PubMed
34014421Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System.Cell Mol Neurobiol2022https://conductscience.org/library/papers/34014421PubMed
32962225ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis.J Clin Med2020https://conductscience.org/library/papers/32962225PubMed
32940851[Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study].Ophthalmologe2021https://conductscience.org/library/papers/32940851PubMed
32908630Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside.Oxid Med Cell Longev2020https://conductscience.org/library/papers/32908630PubMed
32855652Endogenous asymmetric dimethylarginine accumulation contributes to the suppression of myocardial mitochondrial biogenesis in type 2 diabetic rats.Nutr Metab (Lond)2020https://conductscience.org/library/papers/32855652PubMed
32488174Targeted metabolomic analysis of serum amino acids in the adult Fontan patient with a dominant left ventricle.Sci Rep2020https://conductscience.org/library/papers/32488174PubMed
31993367Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer.Front Oncol2019https://conductscience.org/library/papers/31993367PubMed

See all 126 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10069780

GET https://conductscience.org/api/papers/v1/10069780/cited_by?page=2